9.00 – 10.30

REGISTRATION (Hall: Foyer 2)

TOP WORKSHOP ON SUBSTITUTION TREATMENT

Hall: E1  

10.00 - 13.00

METHADONE

Robert  Newman (USA)

Andrej Kastelic (Slovenia)
Zvonka Dremelj (Slovenia):  Urine tests

13.00

LUNCH  (Only for the workshop participants)

13.30 – 15.30

REGISTRATION (Hall: Foyer 2)

TOP WORKSHOP ON SUBSTITUTION TREATMENT (Workshop and dinner are sponsored by Schering Plough)

Hall: Kosovel

15.00 – 18.00

SUBOXONE 

Johan Kakko (Sweden): Methadone assisted treatment vs. a stepped strategy utilizing buprenorphine and methadone:

Results of the Swedish 3G study (69)

Erik Gunderson (USA): Buprenorphine-naloxone as part of general medical practice: the US experience (76)

James Bell (UK): Australian trials of buprenorphine-naloxone (61)

Andrej Kastelic  (Slovenia):  The Slovenian experience with buprenorphine  

18.30

DINNER

8.30 – 10.00

REGISTRATION (Hall: Foyer 2)

TOP WORKSHOP ON SUBSTITUTION TREATMENT

Hall: Kosovel  

9.30 – 11.00

Robert  Haemmig (Switzerland):  Heroin prescription in Switzerland: heroin assisted treatment helps to better understand opioids (Practice

and Results)  (67)

Peter Hofmann (Austria):  Naltrexone  (Presentation is sponsored by Torrex – Chiesi)

11.00 – 11.30

BREAK

TOP WORKSHOP ON SUBSTITUTION TREATMENT (Workshop is  sponsored by Medis)

11.30 – 13.30

SR MORPHINE

Gabriele Fisher (Austria)

Goran Dubajić (Slovenia)

Jasna Čuk Rupnik (Slovenia) 

13.30

LUNCH  (Only for the workshop participants)

12.00 - 20.00

REGISTRATION (Hall: Foyer 2)

15.00 – 16.30

PLENNARY SESSION

Hall: Kosovel  

Chairs: Gabriele Fisher, Mark Parrino

Robert  Newman (USA): Development of ST

Sebastian Saville (UK): International Drug Policy Consortium

Lars Moller (WHO):  Health in prisons and ST (54)

Gabriele Fisher (Austria): Women and ST

James Bell (UK): Specialty recognition of addiction medicine in Australia (16)

16.30 – 17.00

BREAK

17.00 – 18.45

OPENING PLENNARY

Hall: Kosovel  

Chairs: Annette Verster, Andrej Kastelic

Fabienne Hariga (UNODC): UNODC policy and access to ST

Annette Verster (WHO): Evidence for ST treatment

Stijn Goossens (INPUD): The role of  INPUD

Mark Parrino (USA): The role of AATOD

Icro Maremmani (Italy): The role of EUROPAD

19.00 – 20.00

OPENING CEREMONY:

The conference will be opened by Lord Mayor of Ljubljana, ZORAN JANKOVIČ

Hall: Kosovel  

Icro Maremmani, EUROPAD

Mark Parrino, AATOD

Fabienne Hariga, UNODC

 Annette Verster, WHO

Robert  Newman,  ICAAT

Andrej Kastelic, SEEA net

MOJCA HORVAT YOUTH DANCE COMPANY: CHILDREN FROM THE STATION ZOO - FRAGMENTS

20.00 – 22.00

WELCOME RECEPTION

8.00 - 20.00

REGISTRATION (Hall: Foyer 2)

9.00 - 11.00

PLENNARY SESSION I

Hall: Štih

Chairs: Irina Grishayeva, Icro Maremmani

Raminta Stuikyte, Genci Mucollari (CEEHRN): Substitution treatment in Central-Eastern Europe and Central Asia (57)

Milena Naydenova (Bulgaria): Substitution treatment (17)

Irina Grishayeva, Gundo Weiler (Ukraine):  Substitution therapy scale-up in Ukraine – multi- dimensional approach (42)

Luis Patricio (Portugal): Development of opiate addiction treatment  in Portugal

James Bell (UK): What does pharmacology have to do with treatment? (60)

11.00 – 11.30

BREAK

11.30 – 13.30

SPECIAL INTEREST SESSION

Hall: Štih

SPECIAL INTEREST SESSION

Hall: E1

ST IN  PRIMARY HEALTH CARE SETTINGS

Chairs: Ante Ivančić , Jasna Čuk Rupnik

RESEARCH

Chair: Vera Grebenc, Georgi Vasilev

Ante Ivančić (Croatia): Treatment of Opioid Dependence in Primary Health Care (63)

Marc Reisinger (Belgium):  Office based ST

Stephan Walcher (Germany): Primary care settings (78)

Hrvoje Tiljak (Croatia): Methadone to buprenorphine and

buprenorphine to methadone in primary health care – Croatian experience (47)

Nardo Stegelj (Slovenia): ST in private practice in Slovenia

Albrecht Ulmer (Germany): Dihydrocodeine:  A new option for

alcohol addicts (5)

Sergiy Dvoryak (Ukraine): European aspects of the who collaborative study on substitution therapy of opioid dependence and HIV/AIDS (58)

Franz Trautman (The Netherlands), Nino Rode (Slovenia):

Evaluation of the methadone maintenance programmes in Slovenia (50)

Alfred Uhl, Alfred Springer (Austria):  Substitution treatment in Austria (27)

Vera Grebenc, Ines Kvaternik (Slovenia): Researching needs in the community -  drug users as partners in research process (30)

M . Jovanović (Serbia): Neuroimaging techniques  such as CT  and mini mental scale of long-term opiate addicts (66)

13.30 – 14.30

LUNCH

SEEA NET ORGANISATIONAL MEETING (13.45 – 14.30);

Hall: E1

All participants from SEEA region and others  as well, are welcome.

14.30 – 16.30

PARALLEL PLENNARY SESSION II

Hall: Štih

Chair: Ernst Buning

PARALLEL PLENNARY SESSION III

Hall: E1

Chair: Lubomír Okruhlica

Vito Flaker (Slovenia): ST in Everyday Life

Icro Maremmani (Italy): Patient with comorbidity in ST

Mario Sanches (France): ST in France (70)

Peter Vossenberg (The Netherlands):  RIOB: Dutch guideline on opiate maintenance treatment (51)

Vitomir Georgievski (Macedonia): Me, my addiction and the influenze

 of substitution therapy (41)

Tatjana Stamatović, Dušan Mihajlović (Serbia): Substitution therapy - the Belgrade experience (38)

Martin Blakebrough (UK):  Pharmacy dispensing versus community

Stephan Walcher (Germany):  ST interactions (79)

Lubomír Okruhlica, (Slovac Republic): How to cope with methamphetamine epidemics in MMTP (25)

Stijn Goossens (INPUD): Medical assisted treatment of dependency. What about cocaine, amphetamine type stimulants (ATS)? (19)

Albrecht Ulmer (Germany): Dihydrocodeine: Another important substance for opiate addicts (6)

16.30 – 17.00

BREAK

17.00 – 18.45

SPECIAL INTEREST SESSIONS

PRISONS

Hall: Štih

Chair: Holly Catania

POLICY - DIFFERENT PRACTICES

Hall: E1

Chair: Nora Stojanovik, Ante Ivančić

Lars Moller (WHO): Health in prisons – a WHO guide to the essentials

in prison health (New publication from the WHO regional office for Europe) (54)

Fabienne Hariga (UNODC): Framework for HIV AIDS prevention in prisons

Olga Perhavc (Slovenia): Drug addiction treatment in Slovenian

prisons

Dragan Milkov (Serbia): Center for treatment and prevention of drug addiction in Novi Sad county prison (62)

Hoellmueller Huber (Austria): Behavioural paradigms of social care workers in the work with drug addicted persons in alternative

settings (52)

Irina Grishayeva, Gundo Weiler (Ukraine): Preparing

personnel for OST scale-up in Ukraine: adapting the World Health Organization opioid substitution training programme and updating the national OST methadone protocol (43)

Georgi Vasilev (Bulgaria): Working together – day TC and methadone maintenance program (77)

Milazim Gjocaj (Kosovo): Kosovo drugs law, strategy and

policy (20)

Jože Hren (Slovenia): Contribution to the development of drug demand services in Slovenia (29)

Genci Mucollary (Albania): ST in Albania

18.45-19.00

BREAK

19.00

INAUGURAL MEETING – WORLD FEDERATION OF THE ASSOCIATIONS FOR THE TREATMENT OF OPIOID DEPENDENCE

Hall: Štih

Ernst Buning (The Netherlands): Euromethwork: mission complete?(53)

Pat  O’Hare (IHRA)

Mark Parrino (AATOD)

Icro Maremmani (EUROPAD)

Andrej Kastelic (SEEA net)

20.30

WFATOD RECEPTION

8.00 – 16.00

REGISTRATION (Hall: Foyer 2)

9.00-10.30

SPECIAL INTEREST SESSIONS

OVERDOSE AND ST

Hall: Štih

Chair:  Mauro Guarinieri (IHRD)

SEEA NET

Hall: E1

Chair: Nermana Mehić-Basara

Mauro Guarinieri (IHRD): Overdose prevention (65)

Catania Holly (USA): Overdose prevention (72)

Stephan Walcher (Germany): Drug Substitution Emergencies (80)

Eric Schneider (France): From low and high threshold to adapted threshold (1)

Majda Zorec Karlovšek (Slovenia): The forensic aspects of opiate dependence (59)

Mehić-Basara N., Cerić I., Grabovica M. (Bosnia and Herzegovina): Methadone and illicit drugs abuse during the methadone maintenance program (49)

Liljana Ignjatova (Macedonia). Self initiative interruptions of the take home methadone doses are a risk factor for the treatment outcome (2)

Danijela Budiša (Serbia): Algorithm and models of drug addicts’ treatment  in Novi Sad (28)

A.M. Caran, G. Dubajić, A. Kastelic:  Opioid dependence treatment with buprenorphine: a 2-year experience from four Slovenian Slovenian Centers for Prevention and Treatment of Drug Addictions  (48)

Mihai Tanasescu (Romania): Substitution treatment in Romania (75)

10.30– 11.00

BREAK

11.00 – 13.00

SPECIAL INTEREST SESSIONS

HEPATITIS C and ST

Hall: Štih

Chair: Mojca Matičič

TREATMENT

Hall: E1

Chair: Mojca Hvala Cerkovnik

Mojca Matičič (Slovenia):  Management of hepatitis C virus

infection in drug users:  Slovenian experiences and national guidelines (55)

Mauro Guarinieri  (IHRD): Prevention of hepatitis C (64)

Simona Merkinaite, Nora Stojanovik (CEEHRN): Hepatitis C  among drug users in the new EU member states and neighborhood (56)

Milena Naydenova  (Bulgaria): Advocacy for treating HCV (37)

Vratislav Rehak, Laura Krekulova: Hepatitis C antiviral treatment is highly effective in the drug users in the